Navigation Links
Michael J. Fox Foundation Announces Launch of PD Online Research
Date:6/1/2009

-- New Web-based community will increase collaboration and resource-sharing in global PD scientific community --

NEW YORK, June 1 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research announced the launch of PD Online Research (pdonlineresearch.org), a resource-rich virtual workplace that MJFF hopes will become a vibrant Web-based community of PD researchers and funders collaborating and conversing across the globe. MJFF's goal in developing the site is simple: quicker knowledge turns and therefore faster progress in developing transformative new therapies for people with Parkinson's disease.

PD Online is a direct outgrowth of the MJFF's awareness that its own convening power -- which brings together hundreds of research professionals at scores of in-person meetings every year -- is in many ways as important to research progress as is its funding. "Extending the incredibly productive and efficient interactions we see at our meetings to the Web via a scientific social/professional network will provide a platform for thousands of research professionals across the world. It will let them engage daily on key hurdles and hot topics, hopefully accelerating progress and breakthroughs in PD drug development," said Katie Hood, CEO of the MJFF.

The site, which has been conceptualized and built by MJFF in collaboration with Massachusetts General Hospital and the Initiative in Innovative Computing at Harvard University, is a one-stop shop for both an overview of the state of Parkinson's disease research as well as deep dives into top therapeutic targets and technical issues. The Foundation also hopes PDOR will help drive even better decision-making about PD research investment, helping public, nonprofit and private PD investors access a larger pool of experts than ever before, and in the process make smart and timely decisions about the research paths they choose to pursue.

Key content elements of PDOR include:

  • PD Guide -- a continuously updated Parkinson's disease information model that seamlessly delivers all relevant information contained within the site based on users' paths through the content
  • PD Biblio -- a compendium of PD papers in the scientific literature annotated with members' commentary and debate on the authors' assumptions, arguments, and outcomes
  • Virtual Workspaces -- members are free to form or join groups that serve as virtual collaboration hubs within a laboratory or institution, or beyond institutional borders with PD Online members around the world interested in a particular topic
  • Comprehensive listings of funding opportunities and scientific events in PD research and related fields

PD Online Research content is offered as a free resource to the general public. But since MJFF's primary focus is on building a technical hub for Parkinson's research, only scientists, clinicians, allied healthcare professionals directly engaged in scientific research, and investment decision-makers interested in Parkinson's disease in the public, nonprofit, and private sectors will have the ability to post directly to the site. Other interested parties, including people with Parkinson's and their families and members of the general public, will have the ability to read content and discussions and are invited to submit ideas and questions about PD science and therapeutic development to the PD Online team, who will add this input to the PD Online mix where it can help drive discussion and debate forward.

"PD Online will be successful if we can develop a committed and active community all tied to the same goal of accelerating a cure," said Gene Johnson, PhD, chief scientific advisor to MJFF. "But community members really need to believe in the value of the site not only for the greater good, but for their own work. We believe this is possible given the quality of the platform we've developed, and we're excited to see how the community evolves and speeds progress going forward."

To learn more, visit www.pdonlineresearch.org.

The Michael J. Fox Foundation is dedicated to ensuring the development of better treatments, and ultimately a cure, for Parkinson's disease through an aggressively funded research agenda. MJFF has funded over $142 million in research to date. Learn more at www.michaeljfox.org.

    Media Contact: Holly Barkhymer
    (212) 509-0995 x242
    hbarkhymer@michaeljfox.org

    Research Contact: Michael T. Rogan, PhD
    (212) 509-0995 x273
    mrogan@michaeljfox.org


'/>"/>
SOURCE Michael J. Fox Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NPC Newsmaker Program Hosts Briefing on Health Care Reform with Former HHS Secretary Michael Leavitt and Former Senate Majority Leader Tom Daschle
2. Michael Ward Cited for Support of Wounded Warrior Project
3. Majesco Entertainment and Interactive Game Group Announce Two New Jillian Michaels Fitness Video Games
4. Prematics Names S. Michael Ross Chief Medical Officer and Senior Vice President of Business Development
5. Michael J. Fox Foundation Announces $2 Million Funding Commitment to Drive Development of Parkinsons Disease Biomarker Pipeline
6. Celebrated Architect Michael Graves to Keynote HEALTHCARE DESIGN.09 Conference
7. Aleres Dr. Michael Taitel Provides Insights Into Reducing Health and Productivity Costs During Turbulent Economic Times
8. Dr. Michael B. Cates Takes Leadership Role on AVMAs One Health Joint Steering Committee
9. NeuroFocus Appoints Dr. Michael Smith as Partner in Consulting Practice
10. Sigma-Aldrich Announces Appointment of Michael Kanan as Vice President and Corporate Controller
11. J. Michael Cook to Retire from Lilly Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: